Cargando…
A Late Dermatologic Presentation of Bullous Pemphigoid Induced by Anti-PD-1 Therapy and Associated with Unexplained Neurological Disorder
Immunotherapy has become the standard of care for various cancer types. The widespread use of immune checkpoints inhibitors confronts us with a whole range of novel immune-related adverse events. Skin toxicity is one of the most frequent adverse events. In this article, we report a case of anti-PD-1...
Autores principales: | Wang, Xiaoxiao, Suppa, Mariano, Bruderer, Pascal, Sirtaine, Nicolas, Aspeslagh, Sandrine, Kerger, Joseph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8255709/ https://www.ncbi.nlm.nih.gov/pubmed/34248552 http://dx.doi.org/10.1159/000514806 |
Ejemplares similares
-
Bullous pemphigoid and neurological disease: statistics from a
dermatology service()
por: Tarazona, Monica Jidid Mateus, et al.
Publicado: (2015) -
Consensus on the treatment of autoimmune bullous dermatoses: bullous
pemphigoid, mucous membrane pemphigoid and epidermolysis bullosa acquisita -
Brazilian Society of Dermatology
por: Santi, Claudia Giuli, et al.
Publicado: (2019) -
Severe Bullous Pemphigoid Onset after Jugular Catheter Placement in a Patient on Hemodialysis
por: Jacobs, Lucas, et al.
Publicado: (2022) -
Bullous pemphigoid
por: Miyamoto, Denise, et al.
Publicado: (2019) -
Bullous Pemphigoid and Other Pemphigoid Dermatoses
por: Pratasava, Valeryia, et al.
Publicado: (2021)